Trade AUTL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Autolus Therapeutics plc American Depositary Share (AUTL) is trading at US$2.34, down 0.85% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$641.45M. Over the past 52 weeks, AUTL has traded between US$1.18 and US$2.58. On Syfe you can trade AUTL with $0 commission and add it to your watchlist.
| Previous close | US$2.36 |
|---|---|
| Market cap | US$641.45M |
| 52-week range | US$1.18 – US$2.58 |
| Volume | 1.43M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Autolus Therapeutics plc American Depositary Share
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Year: 2018
Mizuho Cuts Price Target on Autolus Therapeutics to $10 From $12, Keeps Outperform Rating
Mar 31, 11:10 AM · MT Newswires
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
Mar 9, 3:30 PM · MT Newswires
Stay on top of AUTL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
